Explore our ISO 13485 certified orthopedic implants, fixation systems, and bone graft solutions supplied to UAE clinical centers.
Understanding the physiological dissolution, osteoconductive kinetics, and local antibiotic carrier capabilities for GCC surgical standards.
Unlike Hydroxyapatite which persists for years, medical-grade alpha-calcium sulphate hemihydrate ($\alpha$-CSH) undergoes simple crystal dissolution in 4 to 8 weeks. This rate synchronized perfectly with new bone apposition, leaving no residual foreign body behind.
As calcium sulphate dissolves, it releases localized calcium ions ($\text{Ca}^{2+}$) into the microenvironment. This localized hypercalcemia stimulates osteoblast proliferation, angiogenesis, and rapid precipitation of endogenous hydroxyapatite crystals.
Calcium sulphate serves as a heat-free vehicle for heat-sensitive antibiotics (Vancomycin, Tobramycin, Gentamicin). It provides prolonged local drug concentrations above minimum inhibitory levels (MIC) without systemic nephrotoxicity.
Evaluating clinical parameters, resorbability, local delivery potential, and economic efficiency for healthcare procurement officers in the UAE.
| Biomaterial Type | Resorption Timeline | Osteogenic mechanism | Antibiotic Delivery Carrier | Exothermic Reaction | Allogenic / Viral Risk |
|---|---|---|---|---|---|
| Alpha-Calcium Sulphate (Ortix CSH) | 4 - 8 Weeks (Complete) | Osteoconductive / Calcium Ion Release | Yes (Heat-free mixing: Vancomycin / Gentamicin) | No (Zero thermal tissue necrosis) | Zero (100% Synthetic) |
| Beta-Tricalcium Phosphate ($\beta$-TCP) | 6 - 12 Months | Osteoconductive | Limited (Porosity dependent) | No | Zero (Synthetic) |
| Sintered Hydroxyapatite (HA) | Years / Non-resorbable | Osteoconductive scaffold | Poor elution profile | No | Zero (Synthetic) |
| PMMA Bone Cement | Non-resorbable permanent | Inert filler (No osteoconduction) | Yes (Restricted to heat-stable antibiotics) | High Exothermic Peak ($>80^\circ\text{C}$) | Zero (Synthetic) |
| Human Allograft (Freeze-Dried Bone) | Variable (3 - 12 Months) | Osteoinductive / Osteoconductive | No | No | Potential immunogenic risk |
Specialized usage scenarios aligned with Dubai Health Authority (DHA), Department of Health Abu Dhabi (DoH), and MOHAP hospital network requirements.
With diabetes prevalence across the GCC region driving high rates of chronic foot ulcers and calcaneal/metatarsal osteomyelitis, orthopedic trauma teams in Dubai and Abu Dhabi rely on biodegradable calcium sulphate beads loaded with Vancomycin or Gentamicin. Filling dead space post-debridement eliminates local bacterial bio-films while eradicating the need for secondary surgical retrieval.
Major trauma centers such as Rashid Hospital (Dubai) and Sheikh Khalifa Medical City (Abu Dhabi) handle complex comminuted fractures resulting from high-velocity motor vehicle accidents. Calcium sulphate paste acts as a structural bone void filler in metaphyseal defects (tibial plateau, distal radius, distal femur), supporting internal locking plates and intramedullary nails.
Dubai's booming dental medical tourism sector demands rapid, reliable bone graft substitutes for alveolar ridge augmentation, sinus floor elevation, and socket preservation. Pure synthetic calcium sulphate provides a radiolucent, zero-infection-risk substrate that resorbs predictably to enable primary dental implant stability within 3 to 4 months.
In posterolateral lumbar fusion (PLF) and transforaminal lumbar interbody fusion (TLIF), calcium sulphate pellets combined with autologous bone marrow aspirate (BMA) serve as an effective graft extender alongside PEEK cages and pedicle screw systems, significantly reducing reliance on donor autografts and donor-site morbidity.
Key economic drivers, procurement mandates, and regulatory approval pathways for medical device distributors in the United Arab Emirates.
The United Arab Emirates healthcare market represents one of the highest per capita medical device spending sectors in the Middle East & North Africa (MENA) region. Medical device imports into the UAE must adhere strictly to registration frameworks governed by the Ministry of Health and Prevention (MOHAP), alongside local regulatory integration with the Department of Health - Abu Dhabi (DoH) and the Dubai Health Authority (DHA).
Key market drivers impacting bone graft substitute procurement across UAE public (SEHA, DHA) and private hospital networks include:
Partnering with Ortix Medical Devices Co., Ltd. delivers institutional reliability, rapid supply chain response, and unmatched quality control.
Modern cleanroom manufacturing infrastructure operating under Class 10,000 and Class 100,000 environmental control protocols.
High-precision multi-axis machining centers ensuring exact dimensional tolerances for surgical hardware and bone graft delivery tools.
Massive daily output capacity guaranteeing reliable lead times and immediate fulfillment of bulk emergency tender orders.
Dedicated biomaterial scientists and orthopedic engineers specializing in synthetic bone graft formulations and OEM customization.
Clear answers to essential regulatory, clinical, and commercial questions for healthcare buyers in the United Arab Emirates.
Ortix Medical provides a complete regulatory documentation package suitable for MOHAP (Ministry of Health and Prevention) product classification and registration. This includes ISO 13485:2016 quality management certification, FDA establishment registration details, CE certificates, full raw material batch analysis, biocompatibility test reports (ISO 10993 series), viral inactivation reports, and 5-year shelf-life stability test data.
Our medical-grade alpha-calcium sulphate hemihydrate powder is supplied in sterile mixing kits. Operating room staff can mix heat-stable antibiotic powders (such as Vancomycin hydrochloride or Tobramycin sulfate) directly with the CSH powder prior to adding the aqueous mixing solution. Because calcium sulphate setting is a non-exothermic hydration reaction, it preserves 100% of the antibiotic’s biological potency.
Yes. We offer complete OEM/ODM solutions tailored for regional distributors. Services include customized kit box dimensions, localized inner blister tray sealing, custom laser marking on injection syringes or bead molds, and bilingual English/Arabic IFU design adhering to GSO and MOHAP labeling guidelines.
We maintain flexible low MOQ options for market entry, allowing mixed-SKU shipments that combine calcium sulphate bone graft kits with titanium locking plates, intramedullary nails, or spinal pedicle screw systems. Standard catalog items ship within 7 to 14 business days, while custom OEM projects follow a clear production schedule via air freight to DXB/DWC or sea freight to Jebel Ali Port.
Yes. Our bone graft kits feature double-sterilized, moisture-impermeable aluminum foil barrier packaging designed specifically to protect the calcium sulphate hemihydrate powder against humidity and thermal degradation. Products maintain full structural integrity and setting performance throughout their standard 3 to 5-year shelf life under ambient tropical storage conditions.
Request evaluation samples, technical dossiers, or a custom OEM quotation for your hospital network or distribution enterprise. Contact our dedicated MENA export division today.